Water-soluble hexasulfobutyl[60]fullerene inhibit low-density lipoprotein oxidation in aqueous and lipophilic phases

Proceedings of the Society for Experimental Biology and Medicine

Volumn 224, Issue 2, 2000, Pages 69-75

  Lee, Yuan Teh ^a   Chiang, Long Yong ^a   Chen, Wei Jao ^a   Hsu, Hsiu Ching ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FULLERENE DERIVATIVE; HEXASULFOBUTYL[60]FULLERENE; LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; AQUEOUS SOLUTION; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; CHEMICAL MODIFICATION; LIPID PEROXIDATION; LIPOPHILICITY; OXIDATION;

ORYCTOLAGUS CUNICULUS;

EID: 0034067626     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1373.2000.22403.x     Document Type: Article

References (38)

1. Chobanian AV. Pathophysiology of atherosclerosis (Review). Am J Cardiol 70:27, 1992.
2. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 20:707-727, 1996.
3. Witzum JL, Steinberg D. Role of oxidized low-density lipoprotein in atherogenesis. J Clin Invest 88:1785-1792, 1991.
4. Carew TE, Schwenke DC, Steinberg D. Anti-atherogenic effect of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low-density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci U S A 84:7725-7729, 1987.
5. Mao SJT, Yates MT, Rechtin AE, Jackson RL, Van-Sickle WA. Antioxidant activity of probucol and its analogues in hypercholesterolemic Watanabe rabbits. J Med Chem 34:298-302, 1991.
6. Sparrow CP, Doebber TW, Olszewski J, Wu MS, Ventre J, Stevens KA, Chao YS. Low-density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N'-diphenyl-phenylenediamine. J Clin Invest 89:1885-1891, 1992.
7. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willet WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 328:1444-1449, 1993.
8. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328:1450-1456, 1993.
9. Kayden HJ, Traber MG. Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. J Lipid Res 34:343-358, 1993.
10. Esterbauer H, Jurgens G, Quehenberger O, Koller E. Autoxidation of human low-density lipoprotein: Loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res 28:495-509, 1987.
11. Bowry VW, Stocker R. Tocopherol-mediated peroxidation: The pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J Am Chem Soc 115:6029-6044, 1993.
12. Taylor R, Walton DRM. The chemistry of fullerenes. Nature 363:685-693, 1993.
13. 60: A new form of carbon. Nature 347:354-358, 1990.
14. Tokuyama H, Yamago S, Nakamura E, Shiraki T, Giura Y. Photo-induced biochemical activity of fullerene carboxylic acid. J Am Chem Soc 115:7918-7919, 1993.
15. Chiang LY, Lu FJ, Lin JT. Free radical scavenging activity of water-soluble fullerenols. J Chem Soc Commun I:1283-1284, 1995.
16. 4. Bioorganic Med Chem Lett 6:539-542, 1996.
17. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 13:341-390, 1992.
18. Yu C, Bhonsle JB, Canteenwala T, Huang JP, Shiea J, Chen BJ, Chiang LY. Novel water-soluble hexa (sulfobutyl) fullerenes as potent free radical scavengers. Chem Lett 11:465-466, 1998.
19. Barclay LR, Locke SJ, Macneil JM, Vankessel J. Autoxidation of micelles and model membranes: Quantitative kinetic measurements can be made by using water-soluble or lipid-soluble chain-breaking with water-soluble or lipid-soluble chain-breaking antioxidants. J Am Chem Soc 106:2479-2481, 1984.
20. Cardin AD, Holdsworth G, Jackson RL. Isolation and characterization of plasma lipoprotein and apolipoprotein. Methods Find Exp Clin Pharmacol 5:146-166, 1984.
21. Lowry OH, Rosebrough NJ, Karr AL, Randall RJ. Protein measurement with the Folin reagent. J Biol Chem 193:265-275, 1973.
22. Frei B, Gaziano JM. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation. J Lipid Res 34:2135-2145, 1993.
23. Sato K, Niki E, Shimasaki H. Free radical-mediated chain oxidation of low-density lipoprotein and its synergistic inhibition by vitamin C. Arch Biochem Biophys 279:402-405, 1990.
24. Esterbauer H, Gstriegl HP, Rotheneder M. Continuous monitoring of in vitro oxidation of human low-density lipoprotein. Free Radic Res Commun 6:67-75, 1989.
25. Knight JA, Pieper RK, McClellan L. Specificity of the thiobarbituric acid reaction: Its use in studies of lipid peroxidation. Clin Chem 34:2433-2438, 1988.
26. Wasowicz W, Neve J, Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: Importance of extraction pH and influence of sample preservation and storage. Clin Chem 39:2522-2526, 1993.
27. Chen MF, Hsu HC, Liau CS, Lee YT. The role of vitamin E on the anti-atherosclerotic effect of fish oil in diet-induced hypercholesterolemic rabbits. Prostaglandins Other Lipid Mediat 57:99-111, 1999.
28. Kuzuya M, Yamada K, Hayashi T, Funaki C, Naito M, Asai K, Kuzuya F. Role of lipoprotein-copper complex in copper catalyzed-peroxidation of low-density lipoprotein. Biochim Biophys Acta 1123:334-341, 1992.
29. Thomas CS, Jackson RL. Lipid hydroperoxide involvement in copper-dependent and independent oxidation of low-density lipoproteins. J Pharmacol Exp Ther 256:1182-1188, 1991.
30. Bowry W, Ingold KU, Stocker R. Vitamin E in human low-density lipoprotein. Biochem J 288:341-344, 1992.
31. Hunt JV, Bottoms MA, Mitchinson MJ. Ascorbic acid oxidation: A potential cause of the elevated severity of atherosclerosis in diabetes mellitus? FEBS Lett 311:161-164, 1992.
32. Retski KL, Frei B. Vitamin C prevents metal ion-dependent initiation and propagation of lipid peroxidation in human low-density lipoprotein. Biochim Biophys Acta 1257:279-287, 1995.
33. Thomes SR, Neuzil J, Mohr D, Stocker R. Co-antioxidants make α-tocopherol an efficient antioxidant for low-density lipoprotein. Am J Clin Nutr 62:1357S-1364S, 1995.
34. Esterbauer H, Qebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 13:341-390, 1992.
35. Jialal I, Grundy SM. Preservation of the endogenous antioxidant in low-density lipoprotein by ascorbate but not probucol during oxidative modification. J Clin Invest 87:597-601, 1991.
36. 60. FEBS Lett 389:111-114, 1996.
37. Steinberg D, Pathasarathy S, Carew T, Khoo JC, Witztum JL. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924, 1989.
38. Witztum JL, Steinberg D. Role of oxidized low-density lipoprotein in atherogenesis. J Clin Invest 88:1785-1792, 1991.